Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries will appoint Jeremy Levin as the new CEO after Shlomo Yanai the current president and CEO of Teva plans to retire from the company with effect from May 2012.
Subscribe to our email newsletter
Levin has recognition for strategic vision and deep knowledge of the pharmaceutical industry and has the demonstrated track record, broad global experience, and leadership skills, the company said.
He has more than 25 years of experience in the global pharmaceuticals industry, major companies and people in the creation, development and delivery of medicines.
Jeremy Levin joined Bristol-Myers Squibb in 2007 and served as Global Head of Business Development and Strategic Alliances at Novartis from 2003 to 2007.
Earlier Levin was CEO of Cadus Pharmaceuticals, a company he took public.